Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

Clinical trial NCT05464745 · COMPLETED

Trial details

NCT number: NCT05464745
Sponsor: Darnitsa Pharmaceutical Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Healthy Subjects

Start date: 2021-05-19
Primary completion: 2021-06-09
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.